SANTHERA PHARMACEUTICALS

santhera-pharmaceuticals-logo

Santhera Pharmaceuticals (SIX: SANN) is a Swiss specialty pharmaceutical company focusing on the development and marketing of innovative pharmaceutical products for the treatment of mitochondrial and neuromuscular diseases. This area of high unmet medical need includes many orphan and niche indications with no current therapy.

#SimilarOrganizations #People #Financial #Event #Website #More

SANTHERA PHARMACEUTICALS

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
2004-09-01

Address:
Liestal, Basel-Landschaft, Switzerland

Country:
Switzerland

Website Url:
http://www.santhera.com

Total Employee:
51+

Status:
Active

Contact:
41 61 906 89 50

Email Addresses:
[email protected]

Total Funding:
187.68 M USD

Technology used in webpage:
Euro Apple Whitelist


Similar Organizations

salix-pharmaceuticals-logo

Salix Pharmaceuticals

Salix Pharmaceuticals is a specialty pharmaceutical companyย focused on theย prevention and treatment of gastrointestinal disorders.

thc-pharm-logo

THC Pharm

THC Pharm develops drugs & medicinal products for the treatment of multimorbidity, cancer and neurological diseases.


Current Advisors List

oliver-strub_image

Oliver Strub Group General Counsel, Secretary to the Board, EVP @ Santhera Pharmaceuticals
Board_member
2006-09-01

Current Employees Featured

toni-perez_image

Toni Perez
Toni Perez Consultant in clinical trials in neuromuscular diseases @ Santhera Pharmaceuticals
Consultant in clinical trials in neuromuscular diseases
2012-06-01

marc-thommen_image

Marc Thommen
Marc Thommen Senior Technical Development and Operations Manager @ Santhera Pharmaceuticals
Senior Technical Development and Operations Manager

thomas-meier_image

Thomas Meier
Thomas Meier Co-Founder, Board Member & Chief Executive Officer @ Santhera Pharmaceuticals
Co-Founder, Board Member & Chief Executive Officer

barbara-polek_image

Barbara Polek
Barbara Polek Head Supply Chain Management & Distribution @ Santhera Pharmaceuticals
Head Supply Chain Management & Distribution

andrew-smith_image

Andrew Smith
Andrew Smith Chief Financial Officer @ Santhera Pharmaceuticals
Chief Financial Officer

shabir-hasham_image

Shabir Hasham
Shabir Hasham Chief Medical Officer & Member of the Executive Management Team @ Santhera Pharmaceuticals
Chief Medical Officer & Member of the Executive Management Team
2022-04-01

dario-eklund_image

Dario Eklund
Dario Eklund Chief Executive Officer @ Santhera Pharmaceuticals
Chief Executive Officer

stephanie-brown_image

Stephanie Brown
Stephanie Brown President Of North America & Member @ Santhera Pharmaceuticals
President Of North America & Member
2021-01-01

Founder


not_available_image

Kristina Schmidt

thomas-meier_image

Thomas Meier

Stock Details


Company's stock symbol is SIX:SANN

Acquisitions List

Date Company Article Price
2009-08-17 Juvantia Pharma Juvantia Pharma acquired by Santhera Pharmaceuticals N/A

Investors List

highbridge-capital-management_image

Highbridge Capital Management

Highbridge Capital Management investment in Post-IPO Debt - Santhera Pharmaceuticals

highbridge-capital-management_image

Highbridge Capital Management

Highbridge Capital Management investment in Post-IPO Equity - Santhera Pharmaceuticals

waypoint-capital_image

Waypoint Capital

Waypoint Capital investment in Post-IPO Equity - Santhera Pharmaceuticals

idorsia_image

Idorsia

Idorsia investment in Post-IPO Equity - Santhera Pharmaceuticals

highbridge-capital-management_image

Highbridge Capital Management

Highbridge Capital Management investment in Post-IPO Debt - Santhera Pharmaceuticals

ya-global_image

YA Global Master SPV

YA Global Master SPV investment in Post-IPO Equity - Santhera Pharmaceuticals

ares-life-sciences_image

Ares Life Sciences

Ares Life Sciences investment in Post-IPO Equity - Santhera Pharmaceuticals

neomed-management_image

Neomed Management

Neomed Management investment in Series C - Santhera Pharmaceuticals

carnegie-asset-management_image

Carnegie Asset Management

Carnegie Asset Management investment in Series C - Santhera Pharmaceuticals

the-dow-chemical-company_image

The Dow Chemical Company

The Dow Chemical Company investment in Series C - Santhera Pharmaceuticals

Official Site Inspections

http://www.santhera.com

  • Host name: staging.santhera.com
  • IP address: 139.162.164.211
  • Location: Frankfurt am Main Germany
  • Latitude: 50.1188
  • Longitude: 8.6843
  • Timezone: Europe/Berlin
  • Postal: 60313

Loading ...

More informations about "Santhera Pharmaceuticals" on Search Engine